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SK channel-mediated metabolic escape to
glycolysis inhibits ferroptosis and supports stress
resistance in C. elegans
Inge E. Krabbendam1, Birgit Honrath1,2,3, Benjamin Dilberger4, Eligio F. Iannetti 5, Robyn S. Branicky6, Tammo Meyer1,
Bernard Evers7,8, Frank J. Dekker 9, Werner J. H. Koopman 10, Julien Beyrath5, Daniele Bano2, Martina Schmidt1,
Barbara M. Bakker7,8, Siegfried Hekimi6, Carsten Culmsee 3,11, Gunter P. Eckert4 and Amalia M. Dolga1
Abstract
Metabolic flexibility is an essential characteristic of eukaryotic cells in order to adapt to physiological and
environmental changes. Especially in mammalian cells, the metabolic switch from mitochondrial respiration to aerobic
glycolysis provides flexibility to sustain cellular energy in pathophysiological conditions. For example, attenuation of
mitochondrial respiration and/or metabolic shifts to glycolysis result in a metabolic rewiring that provide beneficial
effects in neurodegenerative processes. Ferroptosis, a non-apoptotic form of cell death triggered by an impaired redox
balance is gaining attention in the field of neurodegeneration. We showed recently that activation of small-
conductance calcium-activated K+ (SK) channels modulated mitochondrial respiration and protected neuronal cells
from oxidative death. Here, we investigated whether SK channel activation with CyPPA induces a glycolytic shift
thereby increasing resilience of neuronal cells against ferroptosis, induced by erastin in vitro and in the nematode C.
elegans exposed to mitochondrial poisons in vivo. High-resolution respirometry and extracellular flux analysis revealed
that CyPPA, a positive modulator of SK channels, slightly reduced mitochondrial complex I activity, while increasing
glycolysis and lactate production. Concomitantly, CyPPA rescued the neuronal cells from ferroptosis, while scavenging
mitochondrial ROS and inhibiting glycolysis reduced its protection. Furthermore, SK channel activation increased
survival of C. elegans challenged with mitochondrial toxins. Our findings shed light on metabolic mechanisms
promoted through SK channel activation through mitohormesis, which enhances neuronal resilience against
ferroptosis in vitro and promotes longevity in vivo.
Introduction
Metabolic reprogramming towards glycolysis allows for
better cellular fitness to sustain cellular energy in situations
of scarce nutrient availability, hypoxia, or increased energy
demands. Since defects in cellular energy metabolism are
established characteristics of neurodegenerative diseases1–3,
many studies probed for agents with the ability to shift cel-
lular energy metabolism4,5. For example, a small molecule
screening platform identified the commonly used anti-emetic
drug meclizine mediating such metabolic reprogramming
and protecting against cell death in models of stroke and
Huntington’s disease. Recent findings on cell death
mechanisms of neurodegeneration identified ferroptosis, a
non-apoptotic form of cell death, as a trigger for the for-
mation of lipid peroxides and also of mitochondrial dys-
function6–10. Extensive evidence links ferroptosis to the field
of neuroscience with increasing indication for its contribu-
tion to brain degeneration, as detected in Alzheimer’s disease
(AD)8,10. Importantly, inhibitors of ferroptosis were
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protective in models of neurodegeneration6,11,12. Ferroptotic
cell death can be initiated by compounds inhibiting the
cysteine/glutamate antiporter, such as erastin or glutamate,
that mediate depletion of glutathione (GSH), inhibition of
glutathione peroxidase 4 (Gpx4)6,13–15, and lipid peroxide
formation15,16. This results in a boost of mitochondrial
reactive oxygen species (ROS) to such a level that cellular
ROS production exceeds detoxification, causing increased
steady-state ROS levels, and culminating in cell death.
Activation of mitochondrial calcium-activated potas-
sium (mitoKCa) channels mediated neuroprotection in
different models of oxidative toxicity17,18. In particular,
activation of small-conductance calcium-activated potas-
sium (SK/KCa) channels preserved cell survival in condi-
tions of oxidative stress and mitochondrial
dysfunction17,19. In our previous studies, we observed that
SK channel activation alone induced a mild increase in
mitochondrial ROS levels19, leading to the hypothesis that
SK channels might render neuroprotective effects via
mitochondrial preconditioning or mitohormesis20–24.
During mitohormesis, cells and tissues undergo adapta-
tion to oxidative stress where mild stress increases the
resistance of both mitochondria and the whole cell to
subsequent insults20,25. This response has been shown to
protect against an elevated redox balance in many model
organisms. In this regard, in vivo studies in mice and in
the nematode Caenorhabditis elegans (C. elegans) have
revealed that non-toxic mitochondrial ROS levels or
partially inhibited mitochondrial respiration stimulates
pro-longevity programs26,27. For example, C. elegans
mutants with higher mitochondrial ROS levels exhibited
an adaptive response by inducing ROS defense enzymes.
Elevation of this particular ROS signal was necessary and
sufficient to increase lifespan, whereas its inhibition by
antioxidants reduced lifespan28–30.
To date, potential effects of SK channels on mitohormesis
and associated protective effects have not been studied in
association with metabolic reprogramming, nor the sub-
sequent effects on survival in whole organisms exposed to
conditions of oxidative stress. Therefore, the current study
aimed to understand the mechanism by which SK channels
confer neuroprotection during ferroptosis and whether
metabolic reprogramming contributes to its protective
effects.
Results
Activation of SK channels preserves cell survival against
erastin-induced ferroptosis
Here, we investigated whether the observed neuro-
protection was mediated by changes in metabolic pro-
grams of cells. To this end, cells were grown in either
glucose- or galactose-based medium. Compared to
glucose, galactose is used by cells for glycolysis at a
slower rate, due to its slow and energy-demanding
conversion, thereby increasing the cell’s reliance on
OXPHOS for ATP production31–33.
Neuronal HT22 cells represent an established model to
study cellular mechanisms related to erastin-induced
ferroptotic cell death34. Upon application of erastin, cell
viability in both glucose- and galactose-based media was
reduced (Fig. S1). However, in galactose medium, the
effect of erastin on cell viability was less pronounced
compared to cells grown in glucose, indicating that fer-
roptosis induction is accelerated by glucose as carbon
substrate for energy generation. Next, we assessed the
effects of the SK channel opener CyPPA on erastin-
induced toxicity and found that CyPPA prevented cell
death, as detected by the MTT metabolic assay (Figs. 1A,
2A, S1), Annexin/PI (Figs. 1B, 2B) and xCELLigence real-
time impedance measurements (Figs. 1C, 2C, S1A,C). The
MTT assay revealed a reduction of absorbance levels
following CyPPA treatment, indicating an effect of SK
channel activation on the cellular metabolism. However,
analysis of Annexin/PI showed that CyPPA completely
prevented ferroptosis-induced cell death. In addition,
CyPPA reduced both mitochondrial ROS levels and pre-
vented mitochondrial membrane potential (MMP) loss in
erastin-challenged cells (Figs. 1D,E, 2D,E). Notably,
erastin-induced toxicity was more severe in glucose as
indicated by a stronger loss of the MMP and a stronger
increase in mitochondrial ROS levels compared to
galactose conditions. The effect of CyPPA on erastin-
induced mitochondrial superoxide levels was considerably
smaller in galactose medium compared to glucose med-
ium. GSH depletion by BSO had similar effects as erastin
on HT22 cells, i.e., cell viability was reduced, as measured
by MTT assay, Annexin/PI analysis and real-time impe-
dance measurements (Fig. S2A–C). CyPPA was able to
protect against BSO-induced toxicity. Furthermore,
mitochondrial ROS levels were strongly increased by BSO
challenge and co-treatment with CyPPA was able to
prevent the mitochondrial ROS levels (Fig. S2D).
SK channel activation exerts differential effects in glucose
and galactose-based media
In order to delineate the effects of CyPPA on mito-
chondrial function, a mitochondrial “morphofunction”
analysis was performed. A previously established protocol
using multispectral fluorescence and automated micro-
scopy in fibroblasts35 was applied to neuronal HT22 cells.
The TMRM-stained HT22 image processing and data
extraction (Fig. S2A) was performed according to our
previously developed protocol on living primary human
skin fibroblasts35. A representative panel of microscopy
images of the different conditions and timepoints is
shown in Fig. 3. A measure of mitochondrial length
(depicted as ‘aspect ratio’) and of mitochondrial mass
(depicted as ‘cell/mito ratio’), was used as descriptors
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extracted from TMRM microscopy images (Fig. 3C,D, left
panels)35. TMRM was used as an indicator of both
mitochondrial morphology and MMP. Both parameters
were significantly reduced in cells treated with CyPPA in
galactose compared to galactose alone following 24 h and
48 h treatment. In glucose medium, no difference was
observed in mitochondrial length, while only after 48 h a
change in mitochondrial mass was apparent. Mitochon-
drial ‘roundness’, a combined measure of mitochondrial
length and degree of branching, and the average cell size
were significantly reduced upon CyPPA treatment in both
types of media after 24 h and 48 h (Fig. 3C,D). The average
mitochondrial intensity of the TMRM signal (‘density
mean’, Fig. S3) was reduced in glucose and galactose
medium after CyPPA treatment. This is consistent with
HT22 cell treatment with CyPPA resulting in a trend
towards a reduction of MMP (Figs. 1E and 2E) measured
with a different combination of technology and probe
(TMRE/FACS, Figs. 1E and 2E versus TMRM/microscopy
presented in Fig. 3). Descriptors of cell viability, ‘casum’
and the number of nuclei (Nn) were not affected by
CyPPA treatment in glucose at 24 h (Fig. S3B). Cell
numbers quantified on the basis of Nn were slightly
reduced by SK channel activation in galactose medium
(Fig. S3B). After 48 h, in both media the number of nuclei
was reduced (Fig. S3C). Overall, these results suggest that
CyPPA alone slightly reduced MMP, while in the presence
of a cell death inducer, it can prevent cell death and the
pronounced detrimental loss of MMP (Figs. 1E, 2E).
Further, the viability of cells grown in glucose or galac-
tose medium in the absence of erastin was assessed by an
MTT assay (Fig. S4A,B) and cell impedance measurements
(Fig. 4A,C). Our previous studies demonstrated that
CyPPA acts by reducing mitochondrial respiration and
OXPHOS19,36. Although CyPPA (5–10 µM) did not cause
any change in cell viability following 24 h of application,
the higher concentrations of CyPPA (25–50 µM) slightly
reduced cell impedance after 30 h. Glucose replacement
Fig. 1 Activation of SK channels preserves cell survival in conditions of erastin-induced ferroptosis. HT22 cells treated with erastin (1.5 µM,
16 h) in the presence or absence of CyPPA (10 µM or 50 µM) in glucose medium. Cell viability was measured by an a MTT assay and b Annexin V/PI
fluorescence by FACS and c xCELLigence system. CyPPA treatment is represented as grey curves. Mitochondrial function was assessed by FACS
analysis of HT22 cells challenged with erastin (1.5 µM, 16 h) in the presence or absence of CyPPA (10 µM) in glucose. d Mitochondrial superoxide
levels using MitoSOX and e MMP loss using TMRE were determined by FACS analysis. Data are presented as mean ± SD, n= 3–6, *p < 0.05, **p < 0.01,
***p < 0.001, #p < 0.05, ##p < 0.01, ###p < 0.001, *compared to control #compared to erastin alone. All experiments were independently repeated at
least three times.
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with galactose affected cell proliferation and CyPPA
reduced cell viability in a dose-dependent manner. Next,
cells grown in galactose medium showed reduced cell
viability compared to glucose medium in the presence of
mitochondrial complex inhibitors (Fig. 4C–F). In addition,
CyPPA only increased the effects of oligomycin and
rotenone in galactose medium (Fig. 4C–F), in particular
upon rotenone-mediated complex I inhibition. Adding
galactose as a carbon substrate renders the cells less sus-
ceptible to erastin-induced cell death, however, sensitizes
them towards oligomycin, rotenone and to CyPPA itself.
Taken together, these data suggest that CyPPA-mediated
effects on mitochondrial function and cell survival depend
on glucose availability as an energy substrate for glycolysis.
SK channel-mediated increase in glycolytic activity is
essential for neuroprotection
Based on our findings, we hypothesized that in glucose
medium, CyPPA provided protective effects through a
metabolic shift to an increase in glycolytic activity.
In order to investigate whether SK channel activation
actually affects glycolysis, mitochondrial bioenergetics, in
particular the extracellular acidification rate (ECAR) was
assessed. Although O2 consumption rate (OCR) values
did not significantly change in response to short-term
CyPPA application (Fig. S5D), there was a fast and sig-
nificant increase in ECAR following CyPPA application,
that lasted at least 1 h (Fig. 5A,B). In galactose-based
medium, however, CyPPA treatment had milder effects
on glycolysis, with no changes in the glycolytic reserve
(Fig. S5A,B), ATP production (Fig. S5C), and glycolytic
capacity (Fig. S5E,F).
To further strengthen our findings, we assessed lactate
release as another readout of the glycolytic activity. The
enzymatic lactate assay showed a dose-and time-depen-
dent increase in lactate levels in response to CyPPA (Fig.
5C), an effect that was clearly limited in cells grown in
galactose medium (Fig. 5D). To investigate the molecular
mechanisms underlying lactate release in response to
CyPPA stimulation, cells were treated with
Fig. 2 Ferroptotic cell death is prevented by SK channel activation in galactose medium. HT22 cells treated with erastin (1.5 µM, 16 h) in the
presence or absence of CyPPA (10 µM or 50 µM) in galactose medium. Cell survival is shown by a MTT assay, b FACS analysis of Annexin V/PI, and c
xCELLigence system. Mitochondrial function was assessed by FACS analysis of HT22 cells challenged with erastin (1.5 µM, 16 h) in the presence or
absence of CyPPA (10 µM) in glucose. d Mitochondrial superoxide levels using MitoSOX and e MMP loss using TMRE were determined by FACS
analysis. Data are presented as mean ± SD, n= 3–6, *p < 0.05, **p < 0.01, ***p < 0.001, #p < 0.05, ##p < 0.01, ###p < 0.001, *compared to control
#compared to erastin alone. All experiments were independently repeated at least three times.
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Fig. 3 (See legend on next page.)
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dichloroacetate (DCA) that inhibits pyruvate dehy-
drogenase kinase (PDK). DCA attenuated CyPPA-induced
lactate in glucose-based medium, while it elicited no
effects in galactose-based medium (Fig. 5D). DCA alone
slightly reduced cell viability and metabolic activity (Fig.
S6A,D), this effect being more pronounced in galactose
medium, and did not protect against erastin treatment in
glucose- and galactose-based medium (Fig. S6B–E).
Notably, CyPPA-mediated protection was not completely
blocked by co-treatment with DCA indicating that addi-
tional mechanisms may be involved beyond the glycolytic
increase (Fig. 5E,F, Fig. S6C,F).
To further study whether the CyPPA-mediated-increase
in lactate was essential for neuroprotection, cells were
pre-treated for 6 h with lactate before the erastin chal-
lenge. Concentrations of lactate lower than 150 mM did
not exert protective effects (Fig. S6G); however, cell via-
bility assessments revealed that pre-treatment with lactate
protected against erastin in a range of 150–200mM (Fig.
5G). Overall, these findings further support the concept
that a metabolic change towards glycolysis plays a key role
in the SK channel-mediated protection against erastin-
induced ferroptosis.
SK channel activation reduces the activity of mitochondrial
complex I and II
Our previous studies showed that CyPPA reduced
mitochondrial respiration19,36. Here, we observed that
CyPPA is also able to induce an immediate increase in
glycolytic activity that might contribute to protection
against ferroptosis.
To study whether the decrease in mitochondrial
respiration correlated with a decrease in the activity of
mitochondrial complexes, we assessed the direct effect of
CyPPA on mitochondrial complex I- and II-dependent
respiration. High-resolution respirometry measurements
revealed that CyPPA treatment significantly reduced basal
respiration and mitochondrial complex I- and II-linked
respiration (Fig. 6A–C), whereas lower concentrations
exerted milder effects. However, 10 µM CyPPA did reduce
mitochondrial respiration after 6 h treatment, as indicated
by Seahorse measurements (Fig. S8C). In addition, the
maximum uncoupled respiration was reduced in the
presence of CyPPA, which was measured after uncoupling
the respiratory chain with protonophore FCCP (Fig. S7A).
All CyPPA concentrations preserved cell survival in
conditions of ferroptosis (Fig. S1A,C).
SK channel activation induces neuroprotection by
mitochondrial preconditioning
Since inhibition of the glycolytic activity only partially
reduced the neuroprotection mediated by CyPPA and
since opening of the channels slightly decreased complex I
and II activity, this prompted us to investigate whether SK
channel activation provokes a mitochondrial pre-
conditioning effect. To this end, we treated cells with
CyPPA and analyzed mitochondrial superoxide levels and
MMP, observing that SK channel activation for 24 h
increased mitochondrial ROS levels in a dose-dependent
manner (Fig. 6D), and slightly decreased the MMP (Fig. S7B).
Since mitochondrial ROS are pivotal for mitochondrial
preconditioning, we next investigated whether the pro-
duction of mitochondrial ROS was a prerequisite for
CyPPA to provide protection against ferroptosis. To this
end, cells were treated with CyPPA and manganese(III)-
tetrakis(4-Benzoic Acid)porphyrin (MnTBAP), a
mitochondria-targeted SOD mimetic and peroxynitrite
scavenger37,38, prior to and during ferroptosis induction
to scavenge mitochondrial ROS induced by CyPPA
treatment. Treatment with MnTBAP alone exhibited no
effects on cell viability (Fig. S7D,G), and pre-treatment did
not protect against erastin (Fig. S7E) in glucose. In
galactose medium, pre-treatment with MnTBAP slightly
protected against erastin damage, whereas co-treatment
did not (Fig. S7H,I). Notably, MnTBAP alone was able to
decrease mitochondrial ROS levels in the presence of
glucose as well as galactose, and galactose-induced ROS
levels were higher compared to glucose (Fig. S7C). This
might explain the observed protection against erastin
following pre-treatment with MnTBAP in galactose
medium (Fig. 6F,H, Fig. S7I). Notably, in the presence of
CyPPA, MnTBAP reduced mitochondrial ROS levels and
diminished the CyPPA-mediated protection (Fig. 6D–F,
Fig. S7F,J). Thus, CyPPA-induced protection is mediated
by a mild mitochondrial ROS production that can be
attenuated by ROS scavengers.
(see figure on previous page)
Fig. 3 The effects of SK channel activation on mitochondrial morphology. a, b Representative panel of microscopy images of different
conditions and timepoints (TMRM in white, Calcein in green and Hoechst in blue). c, d Mitochondrial “morphofunction” parameters evaluated by
high-resolution microscopy are shown. Aspect ratio, cell mito ratio and roundness are descriptors extracted from TMRM. Integration of cellular and
nuclear descriptors allows calculation of various ‘derived descriptors’ of which ‘norm cyto area’ is depicted in the lower right panel. Panels in
c represent parameters after 24 h of CyPPA (1 µM) treatments, in d after 48 h of treatment in glucose (blue dots) or galactose (pink dots). Data are
presented as mean ± SD, n= 3, ***p < 0.001 versus glucose alone, ##p < 0.01, ###p < 0.001 versus galactose only-treated cells. All experiments were
independently repeated at least three times.
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Assuming that CyPPA enhances glycolysis while
reducing mitochondrial respiration in glucose condi-
tions, we next assessed whether blocking both
mitochondrial ROS and glycolysis, would further prevent
neuroprotection during ferroptosis. To test this, we
combined CyPPA with a treatment of DCA and
Fig. 4 Differential effects in glucose and galactose-based media. a, b Real-time impedance measurements of HT22 cells treated with CyPPA
(5–50 µM, gray curves) in glucose a and galactose b treated for 42 h. Data are presented as mean ± SD, n= 6. c, d MTT assay of HT22 cells treated
with oligomycin, indicated as ‘oligo’ (1, 3, 5 µg/ml, 16 h) in glucose (c) or galactose (d) in the presence or absence of CyPPA (10 µM, gray bars).
e, f MTT assay in HT22 cells treated with rotenone, indicated as ‘rot’ (1, 2.5, 5, 10, 20 nM, 16 h) in glucose (e) or galactose (f) in the presence or absence
of CyPPA (10 µM). Data are presented as mean ± SD, n= 6, *p < 0.05, **p < 0.01, ***p < 0.001, #p < 0.05, ##p < 0.01, ###p < 0.001, *compared to control,
#compared to same rotenone/oligomycin concentration without CyPPA. All experiments were independently repeated at least three times.
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MnTBAP in conditions of ferroptosis (Fig. 6G,H) and
detected that the protection was completely abolished.
These results strongly suggest that both glycolysis and
mitochondrial ROS levels are required for the observed
protective effects of SK channel activation against fer-
roptosis (Fig. 7).
Fig. 5 SK channel-mediated increase in glycolytic activity is critical for neuroprotection. a, b Representative of the normalized extracellular
acidification rate (ECAR) in HT22 cells following the application of CyPPA (5 and 10 µM). Left panel depicts cells treated in glucose, right panel treated
in galactose. b represents area under the curve quantification of the ECAR values presented in panel a, with background subtraction. Data are presented
as mean ± SD, n= 3–6 per condition, *p < 0.05, **p < 0.01 ***p < 0.001 compared to control. c Lactate measurement in medium of HT22 cells in glucose
after treatment with CyPPA (10, 25, 50 µM) for 0, 2, 4, or 6 h. Data are presented as mean ± SD, n= 3 per condition, *p < 0.05, **p < 0.01, ***p < 0.001
CyPPA treatment versus control for the same timepoint d Lactate release following treatment with CyPPA (10 µM) in the presence or absence of
dichloroacetate (DCA, 10mM) for 6 h in glucose (left panel) or galactose (right panel) in HT22 cells (12.000 cells/well). Data are presented as mean ± SD,
n= 3 per condition, **p < 0.01, ***p < 0.001 CyPPA treatment versus control for the same timepoint, ###p < 0.001 combination DCA+ CyPPA treatment
versus CyPPA alone for the same timepoint. e, f MTT assay in HT22 cells treated with erastin (1.5 µM, 16 h, glucose (e), galactose (f)) in the presence or
absence of CyPPA (10 µM gray bars) and pre-treated for 8 h with DCA (10mM) and CyPPA. Data are presented as mean ± SD, n= 6, ***p < 0.001, ###p <
0.001, $$$p < 0.001, *compared to control, #compared to erastin, $compared to erastin + CyPPA. g MTT assay of HT22 cells pre-treated for 6 h with lactate
(150mM) and challenged with erastin (1 or 1.5 μM) for 16 h. All experiments were independently repeated at least three times.
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Fig. 6 (See legend on next page.)
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SK channel activation protects against paraquat and
supports longevity in C. elegans
In order to assess the effects of CyPPA in vivo, we
measured lactate in the nematode C. elegans growing on
CyPPA. Synchronized N2 nematodes were grown on
OP50 ± CyPPA and lactate was measured after four days.
Lactate levels were increased following treatment with
250 µM CyPPA compared to DMSO-treated nematodes,
while 100 µM CyPPA did not affect lactate levels (Fig. 8A).
These results indicated that CyPPA was able to increase
lactate levels both in vitro in neuronal HT22 cells as well
as at a systemic level C. elegans in vivo.
Next, SK channel effects in C. elegans were studied in a
heat-stress survival assay following paraquat exposure.
The heat-stress survival assay is an established method to
study lifespan over a short period of up to 17 h for drug
screening purposes, with predictive potential for the long
term lifespan analysis over three weeks39. Paraquat
induces oxidative stress in nematodes, and indeed it
decreased the survival rate of the nematodes. As illu-
strated in the scheme Fig. 8B, we tested the effects of SK
channel activation on paraquat-dependent toxicity by
exposing the worms to CyPPA for different timepoints
following the initiation of the paraquat insult. CyPPA
treatment for 4 h or 24 h following the insult was not
sufficient to mediate full protection against paraquat-
induced death. Importantly, CyPPA treatment for 48 h
was able to attenuate the paraquat toxicity significantly,
resulting in a higher survival rate (Fig. 8C). Paraquat
induced cell death in HT22 cells as well, from con-
centrations starting at 350 μM. Importantly, CyPPA pre-
served cell viability for concentrations of paraquat up to
500 μM (Fig. S8A,B).
To determine the effect of CyPPA on the lifespan of C.
elegans, we grew wild-type worms for two generations on
NGM plates containing 200 µM CyPPA and monitored
their time of death using the Lifespan Machine40. We
found that CyPPA slightly extended the mean lifespan of
the wild-type animals. No effect on the maximum lifespan
was observed (Fig. 8D). Taken together, we confirmed
that CyPPA targets metabolic programs also in vivo,
thereby conferring protection against oxidative stress in
nematodes.
Discussion
In the present study, we show that SK channel activa-
tion protects against erastin-induced ferroptosis by
mechanisms involving increased initial glycolysis, and a
mild induction of mitochondrial ROS formation. In this
study we delineated consequences of the ability of cells to
use glycolysis as an energy source in conditions of SK
channel activation. We show that CyPPA mediated pro-
tection against ferroptosis, as shown by reduced cell
death, and attenuated mitochondrial ROS levels in med-
ium containing glucose. We suggest that a moderate
inhibition of mitochondrial respiration, complex I activ-
ities, OXPHOS and the concomitant metabolic shifts are
prerequisites for CyPPA-mediated protection. However,
this inhibition also results in enhanced vulnerability to
cell death when cells were grown in the galactose medium
where mitochondrial respiration is the dominating pro-
cess for energy supply. This prompted us to study the
effects of SK channel activation on glycolytic activity. Our
results revealed that SK channel activation mediates a fast
increase in glycolytic activity and an increase in lactate
levels. By increasing the glycolytic capacity, cells can adapt
to maintain energy production in conditions of deficient
mitochondrial respiration. The metabolic switch to aero-
bic glycolysis, characterized by increased lactate levels, is a
common phenotype of cancer cells41–44. This phenom-
enon has also been identified in neurodegenerative dis-
eases such as AD45. For example, increased activity of the
glycolytic enzymes pyruvate kinase and lactate dehy-
drogenase A (LDHA) were elevated in the brain cortex of
AD patients46. Increased levels of PDK1, and con-
comitantly increased activity of LDHA led to enhanced
aerobic glycolysis, which protected against Aß toxicity in
various neuronal lines47,48. DCA is commonly used for its
property to inhibit PDK activity, leading to increased
entry of pyruvate to the TCA. Thus, cells exposed to DCA
undergo more OXPHOS at the expense of glycolysis.
Treatment with this compound was shown to reverse the
(see figure on previous page)
Fig. 6 Mitochondrial ROS is essential for neuroprotection. a–c High-resolution respirometry measurements of the oxygen slope of isolated
mitochondria treated for 10 min with CyPPA (10–50 µM). a measurements of state 2, basal respiration after addition of pyruvate, malate, glutamate.
b complex I-linked respiration was determined after addition of ADP. c complex II-linked respiration after addition of succinate. Data are presented as
mean ± SD, n= 3–5 independent experiments per condition. *p < 0.05, **p < 0.01. Statistical significance is assessed by one-way ANOVA Dunnet’s
multiple comparisons. d Mitochondrial superoxides were measured using MitoSOX after CyPPA (10–50 µM, 24 h) treatment in the presence or
absence of MnTBAP (20 µM). Data are presented as mean ± SD, n= 3, *p < 0.05, ***p < 0.001 versus untreated control, #p < 0.05, ##p < 0.01 versus
CyPPA only-treated cells with the corresponding concentration. e–h MTT assay of cells challenged with erastin, pre (8 h)- and co-treated with CyPPA
(10 µM) in the presence or absence of MnTBAP (20 μM) in glucose (e) and galactose (f). The combination MnTBAP (20 μM) and DCA (10mM) is
depicted in g (glucose) and h (galactose). Data are presented as mean ± SD, n= 6, *p < 0.05, **p < 0.01, ***p < 0.001, ##p < 0.01, ###p < 0.001, $p < 0.05,
$$p < 0.01, $$$p < 0.001, *compared to glucose or galactose control, #compared to erastin, $compared to erastin and CyPPA. All experiments were
independently repeated at least three times.
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glycolytic phenotype in cerebellar granule cells under-
going apoptosis49. DCA allows glycolysis to take place, but
it constrains the aerobic glycolytic pathway observed in
many cancer cells and effectively kills them with limited
cytotoxicity on healthy cells50–53. In our study, when
HT22 cells were co-treated with DCA, both CyPPA-
induced lactate production and the protection against
ferroptosis were significantly decreased. In addition, pre-
and co-treatment with lactate during erastin stimulation
prevented cell death. Even though the increase of lactate
release in response to CyPPA confirms that glycolysis was
enhanced, whether the lactate may contribute to corre-
sponding protection remains to be investigated. Although
high lactate levels result in acidosis in certain forms of
mitochondrial diseases, as well as in stroke, recent data
indicate that lactate, the end-product of glycolysis, may
act as an alternative energy substrate and could promote
neuroprotection in models of ischemic cell death54.
Extracellular application of lactate induced protection
against erastin toxicity, although the protective
Fig. 7 Activation of SK channels prevents ferroptotic cell death. Erastin blocks the Cys/Glu antiporter (XCT) in the plasma membrane leading to
loss of glutathione (GSH) and glutathione peroxidase 4 (GPX4) activity. This enhances the oxidation of lipids by 12/15-lipoxygenases (12/15LOX),
increasing ROS levels, promoting mitochondrial Ca2+ influx and increased ROS levels. Furthermore, ER wraps around mitochondria and initiates
mitochondrial fragmentation, concomitant with the recruitment of dynamin-related protein 1 (DRP1) at the mitochondria to trigger mitochondrial
fission. Activation of SK channels by CyPPA slightly decreases mitochondrial complex I activity and induces a mild increase in mitochondrial ROS
levels. This leads to preconditioning effects, resulting in attenuation of ROS levels in conditions of oxidative stress. However, in the presence of
MnTBAP, ROS are scavenged and this reduces the CyPPA-induced protection. In addition, CyPPA increases lactate production, which contributes to
the observed protection. DCA promotes pyruvate to enter the citric cycle and facilitate more OXPHOS, thereby attenuating the CyPPA effect on
glycolysis. Thus, opening of SK channels contribute to cell survival by increasing glycolytic activity and preventing mitochondrial damage.
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concentrations of lactate were 10 times higher than those
resulting from the cellular lactate release. Therefore, the
expression profile of lactate transporters, such as proton-
linked-monocarboxylate-transporters (MCTs) and
Na+-coupled-electrogenic-transporters in HT22 cells
might provide evidence for these effects. Indeed, admin-
istration of pyruvate after oxygen-glucose deprivation
enhanced the expression of MCT2 and mediated neuro-
protection in HT22 cells55. The neuronal MCT2 trans-
porter may serve to maximize the available energy sources
to the damaged cells. Furthermore, transient and/or
moderate ROS increase can initiate signaling pathways
involved in the stimulation of glucose uptake, as a result
of a cellular adaptation to metabolic stress conditions56.
Overall, these data support the importance of glycolysis in
SK channel-mediated neuroprotection in conditions of
ferroptosis.
In our recent studies, SK channel activation was asso-
ciated with moderately increased mitochondrial ROS and
attenuated mitochondrial respiration, suggesting a
potential involvement in preconditioning pathways19,36,60.
Partial inhibition of mitochondrial complex I by low
concentrations of rotenone provided protection in HT22
cells against glutamate-induced oxidative toxicity57. Our
current results demonstrate that CyPPA decreased the
activity of mitochondrial complex I at higher concentra-
tions than 25 μM on isolated mitochondria, while it
already mediated cytoprotective effects at lower con-
centrations. These acute effects on mitochondrial com-
plex activities were measured on crude mitochondria,
whereas OCR measurements revealed a decrease in
OXPHOS in whole cells after 6 h of CyPPA treatment,
suggesting that the initial increase in glycolytic activity
and the late moderate decrease in mitochondrial
respiration are crucial for CyPPA protection. In addition,
opening of SK channels alone resulted in a slight decrease
in MMP as detected by the FACS and mitochondrial
morphofunctional analysis. Slight decreases in MMP have
been linked before to preconditioning-dependent neuro-
protective pathways58,59, whereas pronounced loss of the
MMP results in mitochondrial dysfunction and cell
death60. Furthermore, when mitochondrial ROS initiated
by CyPPA were scavenged by the antioxidant MnTBAP,
the CyPPA-mediated protection was attenuated. Several
studies showed that MnTBAP is neuroprotective against
oxidative stress61,62, while it may block the protective
Fig. 8 SK channel activation preserves the viability of C. elegans in conditions of mitochondrial stress. a Lactate measurements in C. elegans
following four days of CyPPA treatment (100, 250 µM). Data are presented as mean ± SD, **p < 0.01, b Schematic representation of the heat-stress
experiment. Young adult nematodes were exposed to CyPPA (final concentration 200 µM), paraquat (final concentration 5mM) and a combination of
the two with the same concentrations, with CyPPA treatment for different timepoints. Finally, heat-stress at 37°C is induced to determine lifespan
over 17 h c. In the presence of paraquat exposure, CyPPA treatment for 48 h resulted in a higher survival rate compared to 4 h or 24 h exposure.
Paraquat alone decreased the survival rate (***p < 0.001) and CyPPA (48 h) was able to reverse this effect significantly ##p < 0.01. d Survival curves of
wild-type worms treated with 200 µM CyPPA or 0.1% DMSO as control. The experiment was ended before all the control worms had died. CyPPA
slightly but significantly (p < 0.001) increased the mean lifespan (18.6 ± 3.2 days vs 16.9 ± 2.9 days for the control). Sample sizes are 131 and 101 for
200 µM CyPPA or 0.1% DMSO, respectively.
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effect of large conductance calcium-activated K+ channel
(BK) channels in models of ischemia-reperfusion injury63,
which is in line with our current observations. Interest-
ingly, when combining DCA and MnTBAP, the protec-
tion mediated by CyPPA was even further reduced,
suggesting that both glycolysis and mitochondrial ROS
are essential in SK channel-mediated neuroprotection.
More evidence for SK channel-mediated protection
against oxidative stress derives from our in vivo data. We
demonstrated in C. elegans that SK channel activation
mediated an increase in lactate production and an
improved survival after heat-stress induction. Heat-stress
is an established model mimicking neuronal decline64.
These findings in vivo correspond well with our obser-
vations in HT22 cells in vitro, where CyPPA also provided
protection against paraquat. Moreover, we found that
CyPPA extended the mean lifespan of C. elegans. Previous
studies established that interfering with mitochondrial
function can significantly extend lifespan in C. ele-
gans28,65. Notably, a modest decrease in GSH levels in
young adult worms was shown to mediate stress resis-
tance and promote lifespan66. It has been suggested that
an increase in mitochondrial ROS serves as a pre-
conditioning effect, which involves activation of anti-
oxidant defense mechanisms sustaining cellular
resilience67,68.
In conclusion, our study shows that the activation of SK
channels provides protection against cell death by initi-
ating a metabolic shift towards glycolysis. This metabolic
shift involves a decrease of mitochondrial complex activity
and induction of mitochondrial preconditioning that
renders the cells resistant to oxidative damage.
Materials and methods
Cell culture
HT22 cells were cultured in Dulbecco’s modified Eagle
Medium glucose (DMEM; Gibco, Thermo Fisher Scien-
tific, the Netherlands) enriched with 10% fetal bovine
serum (FBS; GE Healthcare Life Sciences, the Nether-
lands), 100 U/mL penicillin/streptomycin, and 1mM
sodium pyruvate (Gibco, Thermo Fisher Scientific, the
Netherlands) at 37 °C and 5% CO2. HT22 cells were
kindly provided by Prof. Carsten Culmsee (University of
Marburg, Germany) and the passage number used in this
study ranged between 270 and 350. Cells were regularly
tested for Mycoplasma contamination and the study was
performed with Mycoplasma free cells. The treatment
media were prepared supplementing DMEM, no glucose,
no glutamine, no phenol red with: 1 mM sodium pyruvate,
1mM L-glutamine (not in the case of galactose medium),
10% FBS, 100U/ml penicillin/streptomycin, 0.05 mM
Phenol Red (Sigma-Aldrich), and 25mM glucose (Sigma-
Aldrich) for glucose assay medium or 25mM galactose
(Sigma-Aldrich) for galactose-based medium. HT22 cells
were challenged with erastin (Tocris) or various mito-
chondrial complex inhibitors, including rotenone (com-
plex I) (Sigma-Aldrich) and oligomycin (complex V)
(Sigma-Aldrich) for 16 h, or with paraquat (Sigma-
Aldrich) for 24 h. We have obtained similar results when
pyruvate was present or absent in the galactose media.
SK2 channels were pharmacologically activated with the
selective SK2/SK3 channel activator N-Cyclohexyl-N-[2-
(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine
(CyPPA). In attempt to reduce the CyPPA-mediated
protection against erastin, the compounds MnTBAP and
dichloroacetate (Sigma-Aldrich) were used in a pre-
treatment period of 8 h and in the presence of erastin.
Sodium L-lactate (Merck Millipore) was used for cell
culture treatments for 6 h before and during erastin
stimulation.
Cell viability
Cells were seeded with a density of 10.000 cells/well
24 h before treatment. Cell viability was determined based
on the metabolic activity using the 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay at a
final concentration of 0.5 g/L by incubation for 1 h at
37 °C, followed by removal of the MTT (Sigma-Aldrich,
Zwijndrecht, the Netherlands) and at least 1 h incubation
at −20 °C. After dissolution of the resulting formazan in
DMSO, the absorbance of each well was determined with
the Synergy H1 Multi-Mode reader (Biotek, LA, USA) at
570 nm and at 630 nm. Alternatively, cell viability was
monitored in real-time with cell impedance measure-
ments, using the xCELLigence system (Roche Diagnostics,
Penzberg, Germany). Cell impedance was normalized to
the time of treatment (normalized cell index), which is
defined as the starting point (t= 0 h) of the experiment.
Mitochondrial morphofunction
Assay medium preparation, cell seeding and CyPPA
treatment for mitochondrial morphofunctional analysis
The culture medium was prepared supplementing
DMEM, high glucose (#41965039; Thermo Fisher) with:
10% (v/v) Fetal Bovine Serum (FBS; #758093; Greiner Bio-
One, Kremsmünster, Austria), 100 IU/ml penicillin/
streptomycin (#30-002-CI; Corning).
The assay medium was prepared supplementing
DMEM, no glucose, no glutamine, no phenol red
(#A1443001; Thermo Fisher) with: 1 mM sodium pyr-
uvate (#11360070, Life Technologies, Carlsbad, CA, USA),
1 mM L-glutamine (GlutaMAX®; #35050061; Thermo
Fisher), 10% (v/v) Fetal Bovine Serum (FBS; #758093;
Greiner Bio-One, Kremsmünster, Austria), 10 mM
HEPES (#15630080; Thermo Fisher), 100U/ml penicillin/
streptomycin (#30-002-CI; Corning), 0.05 mM Phenol
Red (#3532; Sigma-Aldrich), and 25.5 mM glucose
(#G8270; Sigma-Aldrich, St. Louis, MO, USA) for glucose
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assay medium or 25.5 mM galactose (#G0750, Sigma-
Aldrich) for galactose assay medium. Glucose and galac-
tose assay media were stored at 4 °C in the dark for a
maximum of one month. The SK channel activator
CyPPA was freshly dissolved in DMSO and diluted in
assay medium to a final concentration of 1 µM before
every experiment.
Cells were seeded in culture medium in black 96-well
plates (#655090, Greiner Bio-one) at a density of 4000
cells/well, and incubated overnight in a humidified
atmosphere (95% air, 5% CO2) at 37 °C. The next day,
culture medium was removed and glucose or galactose
assay medium was added. Then, the cells were cultured in
these media for 24 h and 48 h when mitochondrial mor-
phofunctional analysis was performed.
Mitochondrial morphofunctional analysis
Fluorescence microscopy images were acquired from
96-well plates (#655090, Greiner Bio-One) using a BD
Pathway 855® High-Content Bioimager (Becton Dick-
inson, Franklin Lakes, NJ, USA) using a protocol pre-
viously described35. Minor adjustments were introduced
for HT22 cells related to the microscope exposure time
during image acquisition and the threshold to yield a
binary (BIN) image during image processing (Fig. S2A).
An optimal exposure time of 0.2 s and a threshold value of
60 gray values were empirically determined. All other
settings were as previously described. In brief, cells were
co-stained with three fluorescent membrane-permeable
chemical reporters: TMRM (Tetramethyl rhodamine
methyl ester, #T668, Invitrogen), Calcein-AM (#65-0853-
39; Thermo Fisher), and Hoechst 33258 (#94406, Invi-
trogen). TMRM is a cation that accumulates in the
mitochondrial matrix according to the magnitude of the
MMP (depicted in white) Calcein-AM passively accu-
mulates in the cytosol and upon esterase-mediated clea-
vage of its AM (acetoxymethyl) ester tail it becomes green
fluorescent. Hoechst 33258 binds to the AT base pairs in
the minor groove of double-stranded DNA greatly
increasing its blue fluorescence signal. Combination of
cellular and nuclear descriptors allows for calculation of
various ‘derived descriptors’ of which ‘norm cyto area’
reflects a measure of average cell size.
Seahorse XF analysis
HT22 cells were seeded in Seahorse XF 96-well plates
(Seahorse Biosystems). For the experiment with different
concentrations of CyPPA in either glucose-based or
galactose-based medium, the medium was removed
before the measurement and replaced by 180 μL assay
medium containing 2mM L-glutamine, 1 mM pyruvate,
1 g/L BSA and either 25mM glucose or 25 mM galactose
(pH 7.35), for 2 h at 37 °C. The Seahorse XF Biosystem
was used to analyze oxygen consumption rate (OCR) and
extracellular acidification rate (ECAR). Three baseline
measurements (4x min mix, 0 min delay, 4 min measure
= 4/0/4) were recorded followed by injection of CyPPA
(0–10 μM) or medium and measurement for 2 h (4/0/4).
Mitochondrial metabolism was assessed by injection of
3 µM oligomycin (4/0/4), 50 µM dinitrophenol (DNP) (4/
0/4), and 50mM 2-deoxy-D-glucose (2-DG) (4/0/4). After
injection of each compound, OCR and ECAR were
determined. Glycolytic reserve was calculated by sub-
tracting the first two ECAR values after oligomycin
injection. Subtracting the ECAR values after 2-DG injec-
tion from the maximum ECAR values in response to
oligomycin application provided the values of the glyco-
lytic capacity.
In addition, HT22 cells were treated with 10 μM CyPPA
for 6 h, followed by removal of the medium and replace-
ment by 180 μL assay medium containing 2mM L-gluta-
mine, 1 mM pyruvate and 25mM glucose (pH 7.35). The
plate was incubated for 1 h at 37 °C without CO2. Three
baseline measurements (3x min mix, 0 min delay, 3 min
measure= 3/0/3) were recorded, followed by assessment
of mitochondrial metabolism by injection of 4 µM oligo-
mycin (3/0/3), 50 µM DNP (3/0/3), 150 nM rotenone and
1 µM antimycin A, and 50 mM 2-deoxy-D-glucose (2-DG)
(3/0/3).
Lactate measurement in medium from HT22 cells
Cells were seeded in a density of 12.000 cells/well, 24 h
later followed by treatments. Cells were treated with dif-
ferent CyPPA concentrations for 6 h and lactate release
was monitored every 2 h. Medium from HT22 cells was
collected and diluted 10 times in demineralized water. A
calibration curve of eight lactate standards ranging from 0
to 1.2 mM was prepared for quantification purposes.
Subsequently, lactate was measured in a 96-well plate
using 20 µl medium sample or lactate standard mixed
with 225 µl reaction mixture (0.44M Glycine / 0.38M
Hydrazine [pH 9.0], 2.8 mM NAD) and 5 units L-lactic
dehydrogenase (EC 1.1.1.27) followed by absorbance
determination at 340 nm using the SynergyTM H4. All
chemicals were purchased from Merck Millipore. Back-
ground absorbance of the blank control (0.0 mM lactate
standard) was subtracted from all sample readings and
medium samples were corrected for dilution. Medium
lactate concentrations were determined based on linear
regression of the standard curve.
High-resolution respirometry in mitochondria from HT22
cells
Mitochondrial respiration was analyzed by high-
resolution respirometry with the oxygraph O2K (Oro-
boros systems, Innsbruck, Austria). HT22 cells (5–9 ×
107) were collected, and mitochondria were extracted
using a pump-controlled system as described69. In brief,
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dissolved cell pellets in isolation buffer (250 mM sucrose,
20 mM HEPES, 3 mM EDTA, pH 7.5) were gently passed
through the Balch homogenizer with 2 ml glass syringes
fitted with a metal lock for three times70. To break open
and homogenize the HT22 cells a 10 µm ball clearance
was used. The homogenate was centrifuged at 800 × g for
10 min at 4 °C to discard debris. The mitochondria con-
taining supernatant was collected and re-centrifuged at
9000 × g for 10 min at 4 °C. The crude mitochondria-
containing pellet was resuspended in 200 µl of mito-
chondrial respiration medium MirO5 buffer (0,5 mM
EGTA, 3 mM MgCl2, 60mM K-lactobionate, 20 mM
taurine, 10 mM KH2PO4, 20 mM HEPES, 110mM
sucrose, 1 g/L BSA, pH 7,4) developed by Oroboros71. The
mitochondrial respiration of an aliquot of 200 μg crude
mitochondria was monitored under continuous stirring at
750 rpm at 37 °C in 1ml MiR05 buffer after treatment for
10min with vehicle (ethanol) or CyPPA (10–50 μM). For
each measurement 200 µg of treated mitochondria was
added into the 2 ml of air-saturated MirO5 containing
electrode chamber.
Oxygen flux per tissue mass (pmol O2 s
−1 mg−1) was
recorded in real-time using the DatLab software. Non-
phosphorylating respiration was induced by adding the
complex I-linked substrates pyruvate (5 mM) glutamate
(10 mM) and malate (2 mM). The OXPHOS-capacity of
complex I-linked activity was measured after addition of a
saturating concentration of ADP (2.5 mM). Succinate was
applied (10 mM) to determine OXPHOS-capacity of
complex II-linked activity. The maximum respiration was
monitored by stepwise titration of the protonophore
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone
(FCCP) in 1 μM steps. The oxygen concentration and the
first derivative of the oxygen concentration, reported as
the oxygen consumption given in the O2 slope (pmol ×
[ml/s]) of crude isolated mitochondria were recorded at
2 s intervals using instrumental background correction
after calibration of the polarographic oxygen sensors. The
oxygen consumption slope rates were normalized per µg
protein.
Cell death assay
For AnnexinV/PI double staining, the cells were cul-
tured in a 24-well plate format and harvested by using
Trypsin/EDTA after treatment. Cells were incubated in
binding buffer containing AnnexinV-FITC and propidium
iodide (PI) (Fisher Scientific, Landsmeer, Netherlands) at
room temperature for 5 min. Flow cytometric analysis was
performed with excitation at 488 nm and emission at 525/
530 nm for AnnexinV and at 690/50 nm for PI using the
CytoFLEX (Beckman Coulter, Woerden, the Nether-
lands). Dead cells were quantified from AnnexinV, PI and
AnnexinV+PI-positive cells. Data were collected from
15000 cells per condition.
Measurement of mitochondrial superoxide production
Formation of mitochondrial superoxides was deter-
mined with the MitoSOX dye (Fisher Scientific, Land-
smeer, Netherlands). The MitoSOX dye has been proven
to be located within mitochondria in HT22 cells, which
was not influenced by oxidative stress stimuli36 Cells were
incubated with 2.5 µM MitoSOX dye for 30min at 37 °C
and then harvested. Fluorescence was excited at 488 nm
and detected at 690/50 nm using CytoFLEX (Beckman
Coulter, Woerden, the Netherlands). Data were recorded
from 1.5 × 104 cells in triplicate per condition.
Measurement of the mitochondrial membrane potential
(MMP)
Loss of the MMP was assessed with tetramethyl
rhodamine-ethyl ester (TMRE; Fisher Scientific, Land-
smeer, Netherlands) dye. The TMRE dye has been proven
to be located within mitochondria in HT22 cells, which
was not influenced by oxidative stress stimuli36. Cells
were collected and incubated 30 min with 0.2 µM TMRE
at 37 °C. TMRE fluorescence was excited at 488 nm and
detected at 690/50 nm using CytoFLEX (Beckman Coul-
ter, Woerden, the Netherlands). Data were recorded from
1.5 × 104 cells in triplicate per condition.
Lactate measurement in C. elegans
The C. elegans strain N2 was grown on NGM plates and
on OP50 bacteria as a food source. For the lactate mea-
surement, the nematodes were synchronized by bleaching
with NaOH/NaClO and grown on NGM plates contain-
ing OP50 and either DMSO, 100 µM CyPPA or 250 µM
CyPPA for 4 days. To determine lactate levels, the lactate
assay kit was used (Sigma-Aldrich, MAK064). Briefly,
worms were collected and washed to remove OP50. The
worm pellet was snap-frozen, resuspended in lactate assay
buffer and sonicated to break the cuticle. After cen-
trifugation at 13000 rpm for 10min, the supernatant was
applied to a 10 kDa MWCO filter and centrifuged for
60min at 13000 rpm to remove insoluble material. A
standard curve was prepared and 50 µL of the supernatant
was used for the measurement. Fluorescence intensities
(ex535nm/em587nm) were measured using a Tecan
Infinite M Plex platereader (Tecan Group Ltd, Switzer-
land). A Bradford (Sigma-Aldrich, Germany) assay was
performed (595 nm) to determine the protein content
of the sample. Four independent experiments were
performed.
C. elegans heat-stress survival assay
C. elegans and bacterial strains
C. elegans strains were maintained on nematode growth
medium (NGM) agar plates seeded with E. coli OP50 at
20 °C according to standard protocols72. C. elegans wild-
type (N2) was obtained from the Caenorhabditis Genetics
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Center (University of Minnesota, MN, US). For all
experiments, synchronous populations were used that
were obtained by bleaching73.
Heat-stress survival assay at 37 °C
Synchronous nematodes were raised in liquid culture
using NGM liquid and packed E. coli OP50 according to
Stiernagle73. The experiments have 4–5 biological repeats
and only one technical replicate each time. Carbenicillin
was added to the NGM liquid in order to limit further
contamination of the growth medium with other bacteria
or fungi. A volume of 44 μl of NGM liquid was dispensed
in each well of a 96-well microplate (Greiner, Bio-One,
Frickenhausen, Germany), to which 10 μl M9 buffer
containing 10 synchronized L1 larvae was added. L1 lar-
vae were maintained shaking at 20 °C and reached the
young adult stage within 3 days. To young adult nema-
todes a volume of 6 μl effector was added. Effectors were
EtOH:Tween with a final concentration of 1%, CyPPA
with a final concentration of 200 μM, paraquat with a final
concentration of 5 mM and a combination of the two with
the same concentrations. Time till death of the nematodes
was determined 48 h later using a microplate thermo-
tolerance assay as described74. In brief, nematodes were
washed off the wells with M9-buffer into 15 ml tubes
followed by additional three washing steps. In each well of
a black 384-well low-volume microtiter plate (Greiner
Bio-One, Frickenhausen, Germany) 6.5 μl M9-buffer/
Tween® 20 (1% v/v) solution was added. Subsequently,
one nematode was dispensed in 1 μl M9 buffer under a
stereomicroscope (Breukhoven Microscope Systems) into
each well and mixed with 7.5 μl SYTOX green (final
concentration 1 μM; Life Technologies, Karlsruhe, Ger-
many). To prevent water evaporation the plates were
sealed with Rotilab sealing film and covered with a lid
(Greiner Bio-One, Frickenhausen, Germany). Heat shock
(37 °C) was induced and fluorescence was measured with
a ClarioStar Platereader (BMG) every 30min over the
course of 17 h. To detect SYTOX green fluorescence,
excitation wavelength was set to 485 nm and emission was
measured at 538 nm.
Lifespan C. elegans
CyPPA was dissolved in DMSO and added to the NGM
plates to a final concentration of 200 µM. Sample sizes are
131 worms (5 technical repeats) and 101 worms (four
technical repeats) for 200 µM CyPPA or 0.1% DMSO,
respectively. All the data comes from one biological
repeat. 5-fluorodeoxyuridine (FUdR; Sigma F0503) was
dissolved in water and added to the NGM to a final
concentration of 50 µM. Nystatin suspension (Sigma
N1638) was added to the NGM to a final concentration of
100 U/mL. Lifespan analysis was carried out using the
Lifespan Machine, essentially as described40. Worms were
first grown for one full generation on NGM plates con-
taining 200 µM CyPPA. The progeny was transferred to
plates containing 200 µM CyPPA and 5-
fluorodeoxyuridine (FUdR; Sigma F0503) at the young
adult stage. Two days after being transferred to plates
containing FUDR, worms were transferred to the plates to
be used with the lifespan machine, which were made with
the modified NGM as described. These plates also con-
tained 200 µM CyPPA, 50 µM FUDR and 100 U/mL
Nystatin. At each step, control plates contained 0.1%
DMSO instead of 200 µM CyPPA. 30 worms were trans-
ferred to each lifespan machine plate and then placed on
the lifespan machine. Each plate was scanned once per
hour until all worms appeared to have ceased moving.
Time of death was determined using the automated worm
detection and movement analysis software40 and then
validated manually.
Statistics
Statistical significance was assessed using one-way ana-
lysis of variance (ANOVA) followed by Tukey’s comparison
(GraphPad Prism 5.0) unless otherwise stated. For high-
resolution respirometry experiments, statistics were asses-
sed with ANOVA, followed by Dunnet’s comparison. For
the xCELLigence real-time impedance measurements,
MTT assays, and Seahorse extracellular flux analysis at least
three independent experiments with six technical replicates
for each experiment were performed. For FACS measure-
ments and high-resolution respirometry, at least three
independent experiments with three technical replicates for
each experiment were performed. Representative graphs are
shown for the FACS, MTT, lactate, Seahorse, and xCEL-
Ligence measurements. For the mitochondrial morphoa-
nalysis the image processing, quantification, and data
extraction were performed using Image Pro Plus® software
(Media Cybernetics, Rockville, MD, USA) and MATLAB®
scripts (Mathworks, Natick, MA., USA), as previously
described35. Data analysis was performed using Graphpad
PRISM® software (Graphpad Software, San Diego, CA,
USA). Three independent experiments with sixteen tech-
nical replicates each experiment, for a total of 48 replicates
per conditions, were performed. For the heat-stress survival
experiments, curves with an unreadable timepoint of
SYTOX green fluorescence signal increase were excluded.
Otherwise all readable outputs were included. In these
studies, the readout of signal was automated and all groups
were treated in the same way, that no further randomization
was necessary. In addition, the blinding was not necessary
since definite timepoints of signal increase were given. For
the heat-stress survival experiments, statistical analyses
were performed with GraphPad Prism 7.0 software
(GraphPad, La Jolla, CA, USA). Kaplan–Meier survival
curves are shown for survival experiments. Mean lifespans
and C. elegans lactate release were compared using the
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Student’s t-test (GraphPad Prism 7.03). For the lifespan
experiments, animals were randomly assigned to the con-
trol and experiment groups. C. elegans deaths were auto-
matically determined by the analysis software and those that
could not be recognized were automatically excluded by the
recognition software. For all small sample sizes (<5), indi-
vidual data points are plotted. p-values indicating statisti-
cally significant differences between the mean values are
defined as follows: *p < 0.05, **p < 0.01, and ***p < 0.001.
Data are presented as mean ± standard deviation (SD).
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